Critical vulnerabilities in operating systems of different manufacturers
2019.10.09
Ref.: 10746/19
BfArM refers to a publication about potential cybersecurity vulnerabilities in operating systems of different manufacturers issued by FDA:
Medical device manufacturers using these operating systems must implement risk mitigation measures based on their updated risk analysis in light of this vulnerability; see also our recommendation of 28.8.2019 (
).In case of questions please contact:
Federal Institute for Drugs and Medical Devices
Medical Devices Division
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Telephone: +49 (0)228 99 307-5384 (active medical devices and in vitro diagnostics)
Facsimile: +49 (0)228 99 307-5300
E-Mail:
md-vigilance@bfarm.de